跳至主要内容
临床试验/NCT04460599
NCT04460599Unknown不适用

Description of neurolOgical Involvement Observed During SARS COV2 Infection

Centre d'Investigation Clinique et Technologique 8051 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年3月8日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
Primary

研究概览

简要总结

Description of the neurological impairment: clinico-radiological and electrophysilogical correlations

详细描述

Describe short and long term clinical radiological and electrophysilogical presentations of neurological damage central and peripheral SARS COV2 infection Describe the association between neurological, respiratory and dysautonomic Determine the prognosis of neurological damages to short and long term.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • PCR SARS COV2 positive or CT Scan
  • Central neurological signs such as confusion, epilepsy, abnormal movement, pyramidal signs, motor or sensory deficit, involvement of cranial pairs (such as anomie or ageusia) or peripheral.
  • Dysautonomic signs such as hypotension or hypertension, bradycardia or tachycardia, hypothermia, SIADH not explained by therapy or a pathology other than SARS COV 2 infection

排除标准

  • Contraindication to performing an MRI scan
  • Pregnant woman
  • No follow-up possible at 6 months

结局指标

主要结局

Primary

时间窗: 6 months

incidence of objective neurological damage

次要结局

  • Secondary(6 months)

研究者

发起方
Centre d'Investigation Clinique et Technologique 805
申办方类型
Other
责任方
Principal Investigator
主要研究者

david orlikowski

Professor

Centre d'Investigation Clinique et Technologique 805

研究点 (1)

Loading locations...

相似试验